BCAAs in Concussion 3.0
Sponsor: Akiva Cohen • ClinicalTrials.gov ID: NCT07670195
Recruiting for Similar Conditions?
Sponsors are looking for patients like you. See if you qualify for compensated research studies.
Check Eligibility →Description
This study is a randomized, placebo-controlled, double-blinded, therapeutic exploratory clinical trial of branched chain amino acids (BCAAs) in the treatment of concussion. The aim of the study is to determine whether administration of high-dose BCAAs compared to placebo promotes concussion recovery.
Interventions
-
BCAA
(Drug)
The three BCAAs will be combined together into a powder formulation.
-
Placebo
(Other)
The placebo formulation will have similar taste, texture, consistency and appearance as the BCAA formulation.
Eligibility criteria
Conditions
Locations
- Children's Hospital of Philadelphia — Havertown, Pennsylvania, United States
Partner with Nurenyx
Showcase your study to thousands of motivated patients matching your criteria.
Learn MoreOfficial Source
Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
View Official Record